Facing pricing pressure on key drugs Mounjaro and Zepbound in the U.S. and China.

{
  "signal_id": "ee9d020f-415e-4c22-a23d-f8de69a46af4",
  "signal_type": "sec-10q",
  "signal_subtype": "pricingPressure",
  "detected_at": "2026-08-11T08:08:52.209+00:00",
  "company": {
    "name": "Eli Lilly",
    "domain": "lilly.com"
  },
  "data": {
    "detail": "Despite massive sales volume, Lilly is experiencing lower realized prices for its blockbuster drugs due to factors like inclusion on China's National Reimbursement Drug List (NRDL). This puts pressure on margins and increases the need for cost efficiency and revenue management solutions.",
    "metrics": {
      "timeframe": "current_quarter"
    },
    "summary": "Facing pricing pressure on key drugs Mounjaro and Zepbound in the U.S. and China.",
    "excerpts": "In the U.S. for the three and six months ended June 30, 2026, the lower realized prices were primarily driven by Zepbound and Mounjaro...",
    "relevance": 0.8,
    "sentiment": "negative",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/59478/000005947826000081/lly-20260630.htm",
    "filing_date": "2026-08-05",
    "filing_year": 2026,
    "fiscal_year": 0,
    "fiscal_year_end": "06/30",
    "sales_relevance": "Cost optimization needed",
    "signal_category": "market",
    "regions_mentioned": [
      "U.S.",
      "China"
    ]
  }
}

curl https://signals.autobound.ai/v1/signals/ee9d020f-415e-4c22-a23d-f8de69a46af4 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"lilly.com","limit":20}'